These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3086372

  • 1. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
    Nicas TI, Iglewski BH.
    J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
    Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA.
    J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
    [Abstract] [Full Text] [Related]

  • 3. Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields.
    Sokol PA, Cox CD, Iglewski BH.
    J Bacteriol; 1982 Aug; 151(2):783-7. PubMed ID: 6807961
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
    Blackwood LL, Stone RM, Iglewski BH, Pennington JE.
    Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of toxin A excretion-deficient mutants of Pseudomonas aeruginosa PAO1.
    Hamood AN, Ohman DE, West SE, Iglewski BH.
    Infect Immun; 1992 Feb; 60(2):510-7. PubMed ID: 1730483
    [Abstract] [Full Text] [Related]

  • 6. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y, Morihara K, Tsuzuki H, Homma JY, Kato I.
    FEBS Lett; 1980 Oct 20; 120(1):131-4. PubMed ID: 6254804
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical and genetic studies of iron-regulated (exotoxin A) and phosphate-regulated (hemolysin phospholipase C) virulence factors of Pseudomonas aeruginosa.
    Vasil ML, Berka RM, Gray GL, Pavlovskis OR.
    Antibiot Chemother (1971); 1985 Oct 20; 36():23-39. PubMed ID: 2988425
    [No Abstract] [Full Text] [Related]

  • 8. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis.
    Burke V, Robinson JO, Richardson CJ, Bundell CS.
    Pathology; 1991 Apr 20; 23(2):145-8. PubMed ID: 1745565
    [Abstract] [Full Text] [Related]

  • 9. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B, Pavlovskis OR.
    Scand J Infect Dis Suppl; 1981 Apr 20; 29():13-9. PubMed ID: 6797058
    [Abstract] [Full Text] [Related]

  • 10. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI, Iglewski BH.
    Can J Microbiol; 1985 Apr 20; 31(4):387-92. PubMed ID: 2988728
    [Abstract] [Full Text] [Related]

  • 11. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections.
    Hamood AN, Griswold JA, Duhan CM.
    J Surg Res; 1996 Mar 20; 61(2):425-32. PubMed ID: 8656619
    [Abstract] [Full Text] [Related]

  • 12. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse.
    Woods DE, Lam JS, Paranchych W, Speert DP, Campbell M, Godfrey AJ.
    Can J Microbiol; 1997 Jun 20; 43(6):541-51. PubMed ID: 9226874
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.
    Mizukane R, Hirakata Y, Kaku M, Ishii Y, Furuya N, Ishida K, Koga H, Kohno S, Yamaguchi K.
    Antimicrob Agents Chemother; 1994 Mar 20; 38(3):528-33. PubMed ID: 8203850
    [Abstract] [Full Text] [Related]

  • 14. Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources.
    Furuya N, Hirakata Y, Tomono K, Matsumoto T, Tateda K, Kaku M, Yamaguchi K.
    J Med Microbiol; 1993 Aug 20; 39(2):141-6. PubMed ID: 8345509
    [Abstract] [Full Text] [Related]

  • 15. Incidence and level of exotoxin A in proteolytic cell-free cultures of clinical isolates of Pseudomonas aeruginosa collected from hospitals in Riyadh, Saudi Arabia.
    al-Ssum RM.
    Microbiologica; 1992 Oct 20; 15(4):355-9. PubMed ID: 1435349
    [Abstract] [Full Text] [Related]

  • 16. Production of exotoxin, protease and elastase of Pseudomonas aeruginosa strains isolated from patients' and environmental specimens.
    Sanai Y, Takeshi K, Homma JY, Kamata H.
    Jpn J Exp Med; 1978 Dec 20; 48(6):553-6. PubMed ID: 108441
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
    Frank DW, Nair G, Schweizer HP.
    Infect Immun; 1994 Feb 20; 62(2):554-63. PubMed ID: 8300213
    [Abstract] [Full Text] [Related]

  • 19. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.
    Granström M, Wretlind B, Markman B, Pavlovskis OR, Vasil ML.
    Eur J Clin Microbiol; 1985 Apr 20; 4(2):197-200. PubMed ID: 3924608
    [Abstract] [Full Text] [Related]

  • 20. Exotoxin A from various Pseudomonas aeruginosa cultures: in vitro activity measured by enzyme-linked immunosorbent assay (ELISA).
    Ogaard AR, Cryz SJ, Berdal BP.
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun 20; 93(3):217-23. PubMed ID: 3929560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.